The National Aspergillosis Centre is part of the Manchester Fungal Infection Group (MFIG) who have just published an important paper in the very prestigious Nature Communications journal.
Sara Gago in Paul Bowyer’s lab has characterised a mutation carried by people that researchers have found make their airways stickier, thus enabling Aspergillus spores to stick and grow. The implications for infection (ABPA) are pretty clear and the group have already discovered that this mutation is common in people with ABPA (28% of patients in this study had this mutation). This leads us straight to thinking about screening out people who are prone to infection as they carry this gene mutation. We can then pay special attention to prevent them getting ABPA. What this means for people who already have ABPA is less clear, but certainly suggests another target for treatment.
Share this post
Latest News posts
How to use nebulised amphotericin
January 29, 2019
David Haussler: What Can We Learn From Sequencing Our Genomes?
January 29, 2019
Interview with CPA patient
January 29, 2019
Open the windows Poetry & Medicine
January 29, 2019
Bridging the Health Divide in Europe
January 29, 2019
Translational Medicine in Respiratory Disease
January 29, 2019
ERS Vision – Personalising Respiratory Care in Europe
January 29, 2019
Nutritional Science in the Prevention & Management of COPD
January 29, 2019
Designing Drugs to Better Help Real Lives
January 29, 2019
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video